| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974943 | The Journal of Heart and Lung Transplantation | 2005 | 6 Pages |
Abstract
The combined use of an ACE inhibitor and a calcium antagonist is more effective than the individual use of either drug alone on the development of coronary vasculopathy in cardiac transplant recipients. Large randomized clinical trials are warranted to evaluate such a synergistic efficacy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kursad MD, Mohamad H. MD, Randall C. MD, MPH, Tim BS, Robert MD, Corinne MD, Gustavo MD, James B. MD, Jingyuan MS, Daniel J. PhD, Nicholas MD, E. Murat MD,